IL-2 mediates protection against abscess formation in an experimental model of sepsis

J Immunol. 1999 Jul 15;163(2):893-7.

Abstract

Little is known regarding the mechanism by which T cells control intraabdominal abscess formation. Treating animals with polysaccharide A (PS A) from Bacteroides fragilis shortly before or after challenge protects against abscess formation subsequent to challenge with different abscess-inducing bacteria. Although bacterial polysaccharides are considered to be T cell-independent Ags, T cells from PS A-treated animals mediate this protective activity. In the present study, we demonstrate that CD4+ T cells transfer PS A-mediated protection against abscess formation, and that a soluble mediator produced by these cells confers this activity. Cytokine mRNA analysis showed that T cells from PS A-treated animals produced transcript for IL-2, IFN-gamma, and IL-10, but not for IL-4. The addition of IL-2-specific Ab to T cell lysates taken from PS A-treated animals abrogated the ability to transfer protection, whereas the addition of Abs specific for IFN-gamma and IL-10 did not affect protection. Finally, administration of rIL-2 to animals at the time of bacterial challenge prevented abscess formation in a dose-dependent manner. These data demonstrate that PS A-mediated protection against abscess formation is dependent upon a CD4+ T cell-dependent response, and that IL-2 is essential to this immune mechanism.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abdominal Abscess / immunology*
  • Abdominal Abscess / prevention & control
  • Adoptive Transfer
  • Animals
  • Antibody Specificity
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / transplantation
  • Cytokines / antagonists & inhibitors
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • Cytokines / immunology
  • Immune Sera / pharmacology
  • Injections, Intraperitoneal
  • Interleukin-2 / physiology*
  • Interleukin-2 / therapeutic use
  • Male
  • Polysaccharides, Bacterial / administration & dosage
  • Polysaccharides, Bacterial / immunology
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / therapeutic use
  • Sepsis / immunology*
  • Sepsis / prevention & control
  • Solubility

Substances

  • Cytokines
  • Immune Sera
  • Interleukin-2
  • Polysaccharides, Bacterial
  • RNA, Messenger
  • Recombinant Proteins